|
[1]
|
国家癌症中心, 国家肿瘤质控中心甲状腺癌质控专家委员会. 中国甲状腺癌规范诊疗质量控制指标(2022版) [J]. 中华肿瘤杂志, 2022, 44(9): 902-907.
|
|
[2]
|
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L.D., Newbold, K., et al. (2019) Thyroid Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up. Annals of Oncology, 30, 1856-1883. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kitahara, C.M. and Schneider, A.B. (2022) Epidemiology of Thyroid Cancer. Cancer Epidemiology, Biomarkers & Prevention, 31, 1284-1297. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F. and Straif, K. (2016) Body Fatness and Cancer—Viewpoint of the IARC Working Group. New England Journal of Medicine, 375, 794-798. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chen, J., Dalerba, P., Terry, M.B. and Yang, W. (2024) Global Obesity Epidemic and Rising Incidence of Early-Onset Cancers. Journal of Global Health, 14, Article No. 04205. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Pasqual, E., O’Brien, K., Rinaldi, S., Sandler, D.P. and Kitahara, C.M. (2023) Obesity, Obesity-Related Metabolic Conditions, and Risk of Thyroid Cancer in Women: Results from a Prospective Cohort Study (Sister Study). The Lancet Regional Health—Americas, 23, Article ID: 100537. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Prospective Studies Collaboration (2009) Body-Mass Index and Cause-Specific Mortality in 900000 Adults: Collaborative Analyses of 57 Prospective Studies. The Lancet, 373, 1083-1096. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Arnold, M., Pandeya, N., Byrnes, G., Renehan, A.G., Stevens, G.A., Ezzati, M., et al. (2015) Global Burden of Cancer Attributable to High Body-Mass Index in 2012: A Population-Based Study. The Lancet Oncology, 16, 36-46. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wagner, R., Eckstein, S.S., Yamazaki, H., Gerst, F., Machann, J., Jaghutriz, B.A., et al. (2021) Metabolic Implications of Pancreatic Fat Accumulation. Nature Reviews Endocrinology, 18, 43-54. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gong, J., Liu, F., Peng, Y., Wang, P., Si, C., Wang, X., et al. (2024) Sex Disparity in the Association between Metabolic-Anthropometric Phenotypes and Risk of Obesity-Related Cancer: A Prospective Cohort Study. BMC Medicine, 22, Article No. 355. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Song, J., Li, L., Yu, X., Zhan, L., Xu, Z., Li, J., et al. (2021) Association between Metabolic Syndrome and Clinicopathological Features of Papillary Thyroid Cancer. Endocrine, 75, 865-871. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Song, B., Lu, C., Teng, D., Shan, Z. and Teng, W. (2023) Association between Different Metabolic Phenotypes of Obesity and Thyroid Disorders among Chinese Adults: A Nationwide Cross-Sectional Study. Frontiers in Endocrinology, 14, Article ID: 1158013. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Fussey, J.M., Beaumont, R.N., Wood, A.R., Vaidya, B., Smith, J. and Tyrrell, J. (2020) Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 105, e2398-e2407. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Wang, M., Gong, W., Lu, F., Hu, R., He, Q. and Yu, M. (2021) The Association between Diabetes and Thyroid Cancer Risk: A Hospital-Based Case-Control Study in China. BMC Endocrine Disorders, 21, Article No. 21. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Nejadghaderi, S.A., Moghaddam, S.S., Azadnajafabad, S., Rezaei, N., Rezaei, N., Tavangar, S.M., et al. (2022) Burden of Thyroid Cancer in North Africa and Middle East 1990-2019. Frontiers in Oncology, 12, Article ID: 955358. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, X., Yu, Y., Ji, Y., Ma, Z., Tan, J., Jia, Q., et al. (2023) Clinical Characteristics and Therapeutic Response of Differentiated Thyroid Carcinoma with Obesity and Diabetes. BMC Cancer, 23, Article No. 1077. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Marotta, V., Grumetto, L., Neri, I., Russo, G., Tortora, A., Izzo, G., et al. (2023) Exposure to Bisphenol A Increases Malignancy Risk of Thyroid Nodules in Overweight/Obese Patients. Environmental Pollution, 316, Article ID: 120478. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Shin, A., Cho, S., Jang, D., Abe, S.K., Saito, E., Rahman, M.S., et al. (2022) Body Mass Index and Thyroid Cancer Risk: A Pooled Analysis of Half a Million Men and Women in the Asia Cohort Consortium. Thyroid, 32, 306-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kim, K., Kim, K., Lee, S. and Park, S.K. (2023) Sex-Specific Associations between Body Mass Index and Thyroid Cancer Incidence among Korean Adults. Cancer Epidemiology, Biomarkers & Prevention, 32, 1227-1232. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Bell, J.A., Richardson, T.G., Wang, Q., Sanderson, E., Palmer, T., Walker, V., et al. (2022) Effects of General and Central Adiposity on Circulating Lipoprotein, Lipid, and Metabolite Levels in UK Biobank: A Multivariable Mendelian Randomization Study. The Lancet Regional Health—Europe, 21, Article ID: 100457. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wang, H., Li, S., Shi, J., Feng, C., Wang, Y. and Zhang, F. (2023) Unbalanced Bidirectional Causal Association between Thyroid Cancer and Er-Positive Breast Cancer: Should We Recommend Screening for Thyroid Cancer in Breast Cancer Patients? BMC Genomics, 24, Article No. 762. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ahmadi, S., Pappa, T., Kang, A.S., Coleman, A.K., Landa, I., Marqusee, E., et al. (2022) Point of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment. Frontiers in Endocrinology, 13, Article ID: 824226. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Li, C., Zhou, L., Dionigi, G., Li, F., Zhao, Y. and Sun, H. (2020) The Association between Tumor Tissue Calcification, Obesity, and Thyroid Cancer Invasiveness in a Cohort Study. Endocrine Practice, 26, 830-839. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Dong, Z., Liu, W., Su, F. and Cheng, R. (2023) Association of Body Mass Index with Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study. Endocrine Practice, 29, 83-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Shi, P., Zhang, L., Liu, Y., Yang, F., Fu, K., Li, R., et al. (2022) Clinicopathological Features and Prognosis of Papillary Thyroid Cancer Patients with Type 2 Diabetes Mellitus. Gland Surgery, 11, 358-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
O'Neill, R.J., Abd Elwahab, S., Kerin, M.J. and Lowery, A.J. (2021) Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta‐Analysis. World Journal of Surgery, 45, 2805-2815. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wang, H., Wang, P., Wu, Y., Hou, X., Peng, Z., Yang, W., et al. (2020) Correlation between Obesity and Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer: A Study of 1579 Cases: A Retrospective Study. PeerJ, 8, e9675. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Li, C., Zhang, J., Dionigi, G. and Sun, H. (2023) The Relationship between Subclinical Hypothyroidism and Invasive Papillary Thyroid Cancer. Frontiers in Endocrinology, 14, Article ID: 1294441. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Kim, M., Kang, Y.E., Park, Y.J., Koo, B.S., Ku, E.J., Choi, J.Y., et al. (2023) Potential Impact of Obesity on the Aggressiveness of Low-to Intermediate-Risk Papillary Thyroid Carcinoma: Results from a MASTER Cohort Study. Endocrine, 82, 134-142. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Remer, L.F., Linhares, S.M., Scola, W.H., Khan, Z.F. and Lew, J.I. (2022) Transient Hypocalcemia after Total Thyroidectomy: The Obesity Paradox at Work? Journal of Surgical Research, 278, 93-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Mahvi, D.A., Witt, R.G., Lyu, H.G., Gawande, A.A., Nehs, M.A., Doherty, G.M., et al. (2022) Increased Body Mass Index Is Associated with Lower Risk of Hypocalcemia in Total Thyroidectomy Patients. Journal of Surgical Research, 279, 240-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Park, Y., Yu, H.W., Lee, J.K., Choi, J., Kim, W., Kwak, J., et al. (2023) Effect of Body Habitus on Surgical Outcomes Following Bilateral Axillo-Breast Approach Robotic Thyroidectomy: A Retrospective Cohort Study. International Journal of Surgery, 109, 1257-1263. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Huang, L., Feng, X., Yang, W., Li, X., Zhang, K., Feng, S., et al. (2022) Appraising the Effect of Potential Risk Factors on Thyroid Cancer: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 107, e2783-e2791. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Jin, Y.J., Hah, J.H., Kwon, M.J., Kim, J.H., Kim, J., Kim, S., et al. (2022) Association between Thyroid Cancer and Weight Change: A Longitudinal Follow-Up Study. International Journal of Environmental Research and Public Health, 19, Article No. 6753. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Bao, L., Xu, T., Lu, X., Huang, P., Pan, Z. and Ge, M. (2021) Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment. Frontiers in Oncology, 11, Article ID: 773028. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhang, Z., Du, J., Shi, H., Wang, S., Yan, Y., Xu, Q., et al. (2022) Adiponectin Suppresses Tumor Growth of Nasopharyngeal Carcinoma through Activating AMPK Signaling Pathway. Journal of Translational Medicine, 20, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Biswas, P., Datta, C., Rathi, P. and Bhattacharjee, A. (2022) Fatty Acids and Their Lipid Mediators in the Induction of Cellular Apoptosis in Cancer Cells. Prostaglandins & Other Lipid Mediators, 160, Article ID: 106637. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Kushchayeva, Y., Kushchayev, S., Jensen, K. and Brown, R.J. (2022) Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer. Cancers, 14, Article No. 555. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Zhou, X., Zhang, J., Lv, W., Zhao, C., Xia, Y., Wu, Y., et al. (2022) The Pleiotropic Roles of Adipocyte Secretome in Remodeling Breast Cancer. Journal of Experimental & Clinical Cancer Research, 41, Article No. 203. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Masone, S., Velotti, N., Savastano, S., Filice, E., Serao, R., Vitiello, A., et al. (2021) Morbid Obesity and Thyroid Cancer Rate. a Review of Literature. Journal of Clinical Medicine, 10, Article No. 1894. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Walczak, K. and Sieminska, L. (2021) Obesity and Thyroid Axis. International Journal of Environmental Research and Public Health, 18, Article No. 9434. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Scherer, P.E. (2016) The Multifaceted Roles of Adipose Tissue—Therapeutic Targets for Diabetes and beyond: The 2015 Banting Lecture. Diabetes, 65, 1452-1461. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Nigro, E., Orlandella, F.M., Polito, R., Mariniello, R.M., Monaco, M.L., Mallardo, M., et al. (2021) Adiponectin and Leptin Exert Antagonizing Effects on Proliferation and Motility of Papillary Thyroid Cancer Cell Lines. Journal of Physiology and Biochemistry, 77, 237-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Refahi, R., Heidari, Z. and Mashhadi, M. (2023) Association of High Serum Leptin Level with Papillary Thyroid Carcinoma: A Case-Control Study. International Journal of Hematology-Oncology and Stem Cell Research, 17, 210-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Hanahan, D. (2022) Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12, 31-46. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
He, W., Sun, Y., Ge, J., Wang, X., Lin, B., Yu, S., et al. (2023) STRA6 Regulates Tumor Immune Microenvironment and Is a Prognostic Marker in Braf-Mutant Papillary Thyroid Carcinoma. Frontiers in Endocrinology, 14, Article ID: 1076640. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Liu, C., Zhang, Y., Lim, S., Hosaka, K., Yang, Y., Pavlova, T., et al. (2017) A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis. Clinical Cancer Research, 23, 4769-4779. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Li, B., Sun, S., Li, J., Yuan, J., Sun, S. and Wu, Q. (2023) Adipose Tissue Macrophages: Implications for Obesity-Associated Cancer. Military Medical Research, 10, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Avagliano, A., Fiume, G., Bellevicine, C., Troncone, G., Venuta, A., Acampora, V., et al. (2022) Thyroid Cancer and Fibroblasts. Cancers, 14, Article No. 4172. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Pu, W., Shi, X., Yu, P., Zhang, M., Liu, Z., Tan, L., et al. (2021) Single-Cell Transcriptomic Analysis of the Tumor Ecosystems Underlying Initiation and Progression of Papillary Thyroid Carcinoma. Nature Communications, 12, Article No. 6058. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
朱莉, 张雪梅, 周贵明, 等. 癌相关成纤维细胞在甲状腺癌中的表达及临床相关性初步研究[J]. 中华内分泌代谢杂志, 2023, 39(9): 739-745.
|
|
[53]
|
Ferrari, S.M., Fallahi, P., Galdiero, M.R., Ruffilli, I., Elia, G., Ragusa, F., et al. (2019) Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. International Journal of Molecular Sciences, 20, Article No. 4413. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Bergers, G. and Fendt, S. (2021) The Metabolism of Cancer Cells during Metastasis. Nature Reviews Cancer, 21, 162-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Fendt, S., Frezza, C. and Erez, A. (2020) Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy. Cancer Discovery, 10, 1797-1807. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Cheng, C., Fang, W., Yang, Y. and Lin, J. (2024) High Fatty Acid-Binding Protein 4 Expression Associated with Favorable Clinical Characteristics and Prognosis in Papillary Thyroid Carcinoma. Endocrine Pathology, 35, 245-255. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Li, Q., Wang, Y., Meng, X., Wang, W., Duan, F., Chen, S., et al. (2024) METTL16 Inhibits Papillary Thyroid Cancer Tumorigenicity through M6a/Ythdc2/Scd1-Regulated Lipid Metabolism. Cellular and Molecular Life Sciences, 81, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Yang, J., Liu, J., Zhao, S. and Tian, F. (2020) N6-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract. Molecular Therapy—Nucleic Acids, 20, 111-116. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Su, X., Qu, Y. and Mu, D. (2024) Methyltransferase-Like 3 Modifications of RNAs: Implications for the Pathology in the Endocrine System. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1870, Article ID: 167010. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Brenta, G. and Di Fermo, F. (2023) Thyroid Cancer and Insulin Resistance. Reviews in Endocrine and Metabolic Disorders, 25, 19-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Hu, W., Song, R., Cheng, R., Liu, C., Guo, R., Tang, W., et al. (2022) Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology, 13, Article ID: 927859. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Bezin, J., Gouverneur, A., Pénichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., et al. (2022) GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care, 46, 384-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Nagendra, L., BG, H., Sharma, M. and Dutta, D. (2023) Semaglutide and Cancer: A Systematic Review and Meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17, Article ID: 102834. [Google Scholar] [CrossRef] [PubMed]
|